# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-059264
Filing Date
2021-04-30
Accepted
2021-04-30 17:20:35
Documents
6
Period of Report
2021-06-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm212677d2_def14a.htm | DEF 14A | 1201575
2 | GRAPHIC | tm212677d1_def14aimg001.jpg | GRAPHIC | 24254
3 | GRAPHIC | tm212677d1_def14aimg002.jpg | GRAPHIC | 10013
4 | GRAPHIC | tm212677d1_def14aimg003.jpg | GRAPHIC | 11968
5 | GRAPHIC | tm212677d1_def14aimg005.jpg | GRAPHIC | 444458
6 | GRAPHIC | tm212677d1_def14a-img02.jpg | GRAPHIC | 264620
| Complete submission text file | 0001104659-21-059264.txt |  | 2242333

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 21879901
SIC: 2834 Pharmaceutical Preparations